B. Riley Wealth Advisors Inc. purchased a new position in shares of 908 Devices Inc. (NASDAQ:MASS – Free Report) during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 13,000 shares of the company’s stock, valued at approximately $45,000.
Other hedge funds have also recently added to or reduced their stakes in the company. SG Americas Securities LLC bought a new position in shares of 908 Devices in the third quarter worth about $36,000. Drive Wealth Management LLC bought a new position in 908 Devices in the 3rd quarter worth approximately $50,000. Townsquare Capital LLC acquired a new position in 908 Devices during the 3rd quarter worth $50,000. 49 Wealth Management LLC boosted its position in 908 Devices by 16.2% in the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after buying an additional 4,343 shares during the last quarter. Finally, American Century Companies Inc. increased its stake in shares of 908 Devices by 18.6% in the 2nd quarter. American Century Companies Inc. now owns 33,718 shares of the company’s stock valued at $174,000 after buying an additional 5,295 shares during the period. Institutional investors own 88.06% of the company’s stock.
Analysts Set New Price Targets
MASS has been the topic of several research reports. Leerink Partnrs lowered 908 Devices from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Stifel Nicolaus cut their target price on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Finally, Leerink Partners reiterated a “market perform” rating and set a $4.00 price target (down previously from $12.00) on shares of 908 Devices in a research report on Wednesday, November 13th.
908 Devices Stock Up 6.2 %
Shares of 908 Devices stock opened at $2.06 on Monday. The business has a fifty day simple moving average of $2.85 and a 200 day simple moving average of $3.97. 908 Devices Inc. has a 12 month low of $1.82 and a 12 month high of $12.51.
908 Devices Profile
908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.
Further Reading
- Five stocks we like better than 908 Devices
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What is the Nasdaq? Complete Overview with History
- CarMax Gets in Gear: Is Now the Time to Buy?
- The Role Economic Reports Play in a Successful Investment Strategy
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Want to see what other hedge funds are holding MASS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for 908 Devices Inc. (NASDAQ:MASS – Free Report).
Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.